News | April 07, 2025
Fluor to provide EPCM services for pharmaceutical facility in Indiana
This investment is in addition to its first multi-billion-dollar project that was awarded to Fluor in 202
This investment is in addition to its first multi-billion-dollar project that was awarded to Fluor in 202
New facility will support plans to advance J&J’s portfolio and pipeline of transformational medicines for cancer, immune-mediated and neurological diseases
The products will be manufactured in Goa India and marketed & distributed in Australian markets
The inspection, conducted from March 17 to March 21, 2025, concluded with one observation in Form 483
The new site will increase Syngene's total single-use bioreactor capacity to 50,000L
This facility represents a significant step in Croda’s Pharma business strategy to ‘Empower biologics delivery’
The European regulator will conduct a re-inspection of the facility to verify the compliance
Overall investment in the US facility is estimated around US$50 million
This addition strengthens Dr. Agarwals Eye Hospital's vast network of 28 hospitals across Karnataka and 220+ facilities worldwide
The company will provide the necessary response on these observations to USFDA within stipulated 15 days
Subscribe To Our Newsletter & Stay Updated
